{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:00:57Z","timestamp":1769011257143,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.micpath.2021.104888","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:55:58Z","timestamp":1619531758000},"page":"104888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Genetic immunization against toxoplasmosis: A review article"],"prefix":"10.1016","volume":"155","author":[{"given":"Narjes","family":"Yektaeian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-448X","authenticated-orcid":false,"given":"Abdorrasoul","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-6423","authenticated-orcid":false,"given":"Amir","family":"Atapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104888_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00037","article-title":"Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact","volume":"15","author":"Stelzer","year":"2019","journal-title":"Food and Waterborne Parasitol."},{"issue":"9","key":"10.1016\/j.micpath.2021.104888_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii: status, challenges and future directions","volume":"8","author":"Liu","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10096-018-03442-6","article-title":"A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii","volume":"38","author":"Dodangeh","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104888_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00054","article-title":"Toxoplasmosis: overview from a one health perspective","volume":"15","author":"Djurkovi\u0107-Djakovi\u0107","year":"2019","journal-title":"Food and Waterborne Parasitol."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-04094-2","article-title":"Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain","volume":"13","author":"Liu","year":"2020","journal-title":"Parasites Vectors"},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.104888_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00053","article-title":"A one health approach to vaccines against Toxoplasma gondii","volume":"15","author":"Innes","year":"2019","journal-title":"Food and Waterborne Parasitol."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-3954-1","article-title":"The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967\u20132017): a systematic review and meta-analysis","volume":"13","author":"Montazeri","year":"2020","journal-title":"Parasites Vectors"},{"issue":"2","key":"10.1016\/j.micpath.2021.104888_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10393-019-01405-7","article-title":"The one health approach to toxoplasmosis: epidemiology, control, and prevention strategies","volume":"16","author":"Aguirre","year":"2019","journal-title":"EcoHealth"},{"issue":"12\u201313","key":"10.1016\/j.micpath.2021.104888_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"10","key":"10.1016\/j.micpath.2021.104888_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention","volume":"8","author":"Hill","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3923\/ajava.2010.210.216","article-title":"The seroprevalence of bovine toxoplasmosis in Fars Province, Southern Iran","volume":"5","author":"Asgari","year":"2010","journal-title":"Asian J. Anim. Vet. Adv."},{"issue":"6","key":"10.1016\/j.micpath.2021.104888_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00580-011-1300-x","article-title":"Clinical, serological and histopathological signs of toxoplasmosis in broiler chickens (Gallus domesticus) after experimental infection","volume":"21","author":"Derakhshanfar","year":"2012","journal-title":"Comp. Clin. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2021.104888_bib14","first-page":"5772","article-title":"Toxoplasmosis\u2013a waterborne zoonosis","volume":"126","author":"Dubey","year":"2004","journal-title":"Vet. Parasitol."},{"issue":"2","key":"10.1016\/j.micpath.2021.104888_bib15","article-title":"Toxoplasmosis, pancreatitis, obesity and drug discovery","volume":"4","author":"Oz","year":"2014","journal-title":"Pancreat. Disord. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2021.104888_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"9425","key":"10.1016\/j.micpath.2021.104888_bib17","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/mi.2017.102","article-title":"T-bet-independent Th1 response induces intestinal immunopathology during Toxoplasma gondii infection","volume":"11","author":"L\u00f3pez-Yglesias","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.1501558","article-title":"The IL-12 response of primary human dendritic cells and monocytes to Toxoplasma gondii is stimulated by phagocytosis of live parasites rather than host cell invasion","volume":"196","author":"Tosh","year":"2016","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exppara.2005.11.009","article-title":"Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts","volume":"112","author":"Nielsen","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2021.104888_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.micinf.2018.05.006","article-title":"Granulocyte macrophage colony-stimulating factor alone reduces Toxoplasma gondii replication in microglial culture by superoxide and nitric oxide, without IFN-\u03b3 production: a preliminary report","volume":"20","author":"Pimenta","year":"2018","journal-title":"Microb. Infect."},{"key":"10.1016\/j.micpath.2021.104888_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.schres.2017.02.009","article-title":"Stability of Toxoplasma gondii: antibody levels in schizophrenia","volume":"189","author":"Yuksel","year":"2017","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.actatropica.2006.11.002","article-title":"Prevalence of latent and reactivated Toxoplasma gondii parasites in HIVpatients from Uganda","volume":"100","author":"Lindstrom","year":"2006","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2021.104888_bib24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3389\/fmicb.2019.01875","article-title":"Immunization with a Live-attenuated RH: \u0394NPT1 strain of Toxoplasma gondii induces strong protective immunity against Toxoplasmosis in mice","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2021.104888_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: a mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"J. Adv. Veterin. Animal Res."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11599\/germs.2013.1034","article-title":"DNA vaccines: roles against diseases","volume":"3","author":"Khan","year":"2013","journal-title":"Germs"},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/AIHB.AIHB_74_17","article-title":"DNA vaccine: methods and mechanisms","volume":"8","author":"Soltani","year":"2018","journal-title":"Adv. Human Biol."},{"key":"10.1016\/j.micpath.2021.104888_bib28","series-title":"Plasmid","article-title":"Plasmid-Based DNA vaccines","author":"G\u00f3mez","year":"2018"},{"issue":"11","key":"10.1016\/j.micpath.2021.104888_bib29","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms19113605","article-title":"DNA vaccines\u2014how far from clinical use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2021.104888_bib30","first-page":"92","article-title":"DNA Vaccine: mechanism of Action and factors which increase its efficacy","volume":"7","author":"Yurina","year":"2018","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.micpath.2021.104888_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0353-9","article-title":"Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection","volume":"51","author":"Sasai","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.micpath.2021.104888_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.pt.2011.03.009","article-title":"Innate responses to Toxoplasma gondii in mice and humans","volume":"27","author":"Pifer","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2021.104888_bib33","series-title":"Seminars in Immunopathology","article-title":"Immune response and immunopathology during toxoplasmosis","author":"Dupont","year":"2012"},{"issue":"12","key":"10.1016\/j.micpath.2021.104888_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008097","article-title":"Human immunity to Toxoplasma gondii","volume":"15","author":"Fisch","year":"2019","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/intimm\/dxy004","article-title":"Host immune responses to Toxoplasma gondii","volume":"30","author":"Sasai","year":"2018","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2021.104888_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.vaccine.2007.11.058","article-title":"An enhanced GRA1\u2014GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs","volume":"26","author":"Jongert","year":"2008","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2021.104888_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(03)00377-6","article-title":"Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies","volume":"266","author":"Bivas-Benita","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2021.104888_bib38","article-title":"Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154","author":"Hiszczy ska-Sawicka","year":"2011","journal-title":"Vet. Parasitol."},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14760584.2015.1011133","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice","volume":"14","author":"Chen","year":"2015","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2021.104888_bib40","series-title":"Utilization of Recombinant Influenza Viruses and Modified Vaccinia Ankara Virus (MVA) with Genes that Encode for the Toxoplasma Gondii SAG1 and SAG2 Surface Proteins, as Vaccines against Toxoplasmosis","author":"Gazzinelli","year":"2018"},{"issue":"21\u201322","key":"10.1016\/j.micpath.2021.104888_bib41","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S0264-410X(03)00163-4","article-title":"DNA vaccination with the immunodominant tachyzoite surface antigen (SAG1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission","volume":"21","author":"Couper","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/427660","article-title":"A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts","volume":"191","author":"Beghetto","year":"2005","journal-title":"JID (J. Infect. Dis.)"},{"issue":"9","key":"10.1016\/j.micpath.2021.104888_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-3024.2007.00961.x","article-title":"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii","volume":"29","author":"Jongert","year":"2007","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2021.104888_bib44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.vaccine.2010.11.012","article-title":"Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis","volume":"29","author":"Hoseinian Khosroshahi","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.micpath.2021.104888_bib45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4269\/ajtmh.16-0548","article-title":"Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute toxoplasmosis in BALB\/c mice","volume":"96","author":"Ching","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.micpath.2021.104888_bib46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","article-title":"GRA1 protein vaccine confers better immune response compared to codonoptimized GRA1 DNA vaccine","volume":"25","author":"Doskaya","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rvsc.2010.01.007","article-title":"The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18","volume":"89","author":"Liu","year":"2010","journal-title":"Res. Vet. Sci."},{"issue":"7","key":"10.1016\/j.micpath.2021.104888_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00059-14","article-title":"Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5","volume":"21","author":"Zhang","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2021.104888_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2014.08.011","article-title":"Immunoglobulin and cytokine changes induced following immunization with a DNA vaccine encoding Toxoplasma gondii selenium-dependent glutathione reductase protein","volume":"146","author":"Hassan","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2021.104888_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trivac.2014.04.003","article-title":"A novel dual promoter DNA vaccine induces CD8+ response against Toxoplasma gondii sporozoite specific surface protein \u201cSporoSAG\u201d through non-apoptotic cells","volume":"3","author":"\u0130z","year":"2014","journal-title":"Trials Vaccinol."},{"issue":"9","key":"10.1016\/j.micpath.2021.104888_bib51","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1586\/14760584.2015.1061938","article-title":"Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice","volume":"14","author":"Zhang","year":"2015","journal-title":"Expet Rev. Vaccine"},{"issue":"18","key":"10.1016\/j.micpath.2021.104888_bib52","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.vaccine.2009.02.058","article-title":"Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens","volume":"27","author":"Rosenberg","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104888_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1756-3305-7-431","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice","volume":"7","author":"Hassan","year":"2014","journal-title":"Parasites Vectors"},{"issue":"1\u20133","key":"10.1016\/j.micpath.2021.104888_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2011.03.003","article-title":"Immune response and protective efficacy against homologous challenge in BALB\/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene","volume":"179","author":"Li","year":"2011","journal-title":"Vet. Parasitol."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2021.104888_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.vetpar.2009.08.016","article-title":"Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice","volume":"166","author":"Qu","year":"2009","journal-title":"Vet. Parasitol."},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.exppara.2009.04.002","article-title":"Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice","volume":"122","author":"Wang","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"10","key":"10.1016\/j.micpath.2021.104888_bib57","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.vaccine.2010.12.118","article-title":"Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization","volume":"29","author":"Makino","year":"2011","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.micpath.2021.104888_bib58","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/S0264-410X(03)00157-9","article-title":"Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes","volume":"21","author":"Mohamed","year":"2003","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.micpath.2021.104888_bib59","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","article-title":"Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice","volume":"23","author":"Mevelec","year":"2005","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.micpath.2021.104888_bib60","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.vaccine.2014.03.042","article-title":"Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice","volume":"32","author":"Li","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.micpath.2021.104888_bib61","first-page":"9156","article-title":"Construction and identification of Complex DNA vaccine of hepatitis B and Toxoplasma gondii","volume":"8","author":"Wei","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib62","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1186\/s12879-014-0706-x","article-title":"Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.26703","article-title":"Toxoplasma gondii: immune response and protective efficacy induced by ROP16\/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2","volume":"10","author":"Liu","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"10.1016\/j.micpath.2021.104888_bib64","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.parint.2014.01.002","article-title":"CTL induction by DNA vaccine with Toxoplasma gondii-HSP70 gene","volume":"63","author":"Chu","year":"2014","journal-title":"Parasitol. Int."},{"issue":"31","key":"10.1016\/j.micpath.2021.104888_bib65","first-page":"S67S68","article-title":"DNA vaccine expressing ubiquitin-conjugated multi-fragments antigens protects BALB\/c mice against Toxoplasma gondii infection","author":"Cong","year":"2014","journal-title":"N. Biotech."},{"issue":"3","key":"10.1016\/j.micpath.2021.104888_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.exppara.2008.03.005","article-title":"Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine","volume":"119","author":"Xue","year":"2008","journal-title":"Exp. Parasitol."},{"issue":"31","key":"10.1016\/j.micpath.2021.104888_bib67","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2008.04.046","article-title":"Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii","volume":"26","author":"Cong","year":"2008","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.micpath.2021.104888_bib68","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2008.06.030","article-title":"Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice","volume":"26","author":"Qu","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as Toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12879-017-2507-5","article-title":"Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB\/c mice","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104888_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.micpath.2021.104888_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents","volume":"181","author":"Angus","year":"2000","journal-title":"J. Infect. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021001601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021001601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:08Z","timestamp":1760110568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021001601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":72,"alternative-id":["S0882401021001601"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104888","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic immunization against toxoplasmosis: A review article","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104888"}}